MALAT1 and colorectal cancer: Our Targetscan prediction results revealed that miR-202-3p targeted SRSF1, which was further confirmed by the RNA pull-down and RIP experiments Consistently, SRSF1 has reported being activated by MALAT1 in colorectal cancer cells [27].